EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens

Dana Dildabayeva iD, Diana Samarkhanova iD, Larissa Lezina iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dana Dildabayeva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Phthalazines, Piperazines, Drug Resistance, Neoplasm, Homologous Recombination. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical use of PARP inhibitors (PARPi), including olaparib, has improved outcomes for patients with BRCA1/2-mutant and homologous recombination (HR)-deficient tumors. However, acquired resistance remains a major limitation to their efficacy. CRISPR-Cas9 screening approaches have been developed to identify genetic drivers of PARPi resistance. However, differences in experimental conditions, library coverage, and selection design complicate comparisons across studies. In this review, we present a harmonized reanalysis of CRISPR knockout olaparib resistance screens to identify recurrent resistance-associated genes and pathways. Datasets with raw data were collected from the BioGRID ORCS database. Resistance hits identified in at least two screens were subjected to Reactome pathway-enrichment analysis and organized into functional modules. Using this approach, we identified eight modules: DNA-damage repair and replication stress; cell-cycle regulation; chromatin remodeling and histone modification; post-translational regulation; mitochondrial function; TGF-β and mTOR signaling; RNA processing and nucleocytoplasmic transport; and emerging adaptive mechanisms. Importantly, mitochondrial function genes were observed as recurrent hits, but their relation to olaparib resistance is underinvestigated. Our integrative analysis suggests that PARPi resistance is a complex, adaptive phenotype shaped by recurrent but context-dependent vulnerabilities across multiple cellular programs. This framework prioritizes candidate resistance drivers for validation and highlights directions for the design of combination therapies aimed at overcoming PARPi resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesPiperazinesDrug Resistance, NeoplasmHomologous RecombinationPoly(ADP-ribose) Polymerase InhibitorsCRISPR-Cas SystemsHumansAnimalsDNA Repair

Stichwörter der Autor:innen

CRISPR screenPARP inhibitor resistancefunctional genomicsolaparib

Substanzen

olaparibPhthalazinesPiperazinesPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Biological and Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.

ORCID-Profile: Dana Dildabayeva, Diana Samarkhanova, Larissa Lezina

Förderung

  • Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Dildabayeva, D., Samarkhanova, D., & Lezina, L. (2026). Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209381

Vancouver

Dildabayeva D, Samarkhanova D, Lezina L. Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209381

BibTeX
@article{Dildabayeva2026,
  author = {Dildabayeva, Dana and Samarkhanova, Diana and Lezina, Larissa},
  title = {Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209381}
}
Kostenlos starten →